1. Safety aspects of pegylated liposomal doxorubicin in patients with cancer;Alberts;Drugs,1997
2. Antibodies to cholesterol: principles for practical application;Alving,1998
3. Antibodies to cholesterol, cholesterol conjugates, and liposomes: implications for atherosclerosis and autoimmunity;Alving;Crit. Rev. Immunol.,1991
4. Cholesterol-dependent human complement activation resulting in damage to liposomal model membranes;Alving;J. Immunol.,1977
5. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes;Chonn;J. Immunol.,1991